Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tylenol Delivers J&J Relief As Global 'Consumer Staples' Sales Slump

Executive Summary

J&J says Tylenol outpaced other analgesics in the first quarter as its OTC franchise grew 1.4% on a reported basis to $1.01 bn. CFO Dominic Caruso said new consumer products will add 2 points of incremental growth to the segment in 2017.


Related Content

Switches, Pediatric Products Highlight OTC Outlook In Independent Pharmacies
Independent Pharmacies Stock Growth Opportunities In Health, Wellness And Beauty Aisles
P&G Announces 'Irresistible Superiority' Strategy To Win In Global Slump
'Slow-Growth' Global Trend Shakes Up P&G Product Strategy Start To Finish
Rebates, Pricing Pressure Weigh On J&J's Q1 Pharma Sales
J&J Promotes Preventive Care, Wellness In US Health Debate
Colgate Builds On Oral Care, Counts E-commerce As Emerging Sector
P&G Keeps Direct-to-Consumer In Perspective, Retail Distribution Primary
Expanding $1 Billion Brand Club Fits In J&J Consumer Big Picture


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts